{
    "organizations": [],
    "uuid": "b4126d8c7ae3a9db8daec96b53df77b3ece2d7cb",
    "author": "",
    "url": "https://www.reuters.com/article/brief-fda-approves-janssen-pharmaceutica/brief-fda-approves-janssen-pharmaceuticals-erleada-for-a-certain-type-of-prostate-cancer-idUSFWN1Q41DX",
    "ord_in_thread": 0,
    "title": "BRIEF-FDA Approves Janssen Pharmaceutical's Erleada For A Certain Type Of Prostate Cancer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " FDA Approves Janssen Pharmaceutical's Erleada For A Certain Type Of Prostate Cancer Reuters Staff 1 Min Read Feb 14 (Reuters) - The U.S. Food and Drug Administration: * SAYS APPROVED JANSSEN PHARMACEUTICAL‘S ERLEADA FOR A CERTAIN TYPE OF PROSTATE CANCER USING NOVEL CLINICAL TRIAL ENDPOINT‍​  ",
    "published": "2018-02-14T22:49:00.000+02:00",
    "crawled": "2018-02-14T23:06:11.014+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "fda",
        "approves",
        "janssen",
        "pharmaceutical",
        "erleada",
        "certain",
        "type",
        "prostate",
        "cancer",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "food",
        "drug",
        "administration",
        "say",
        "approved",
        "janssen",
        "pharmaceutical",
        "erleada",
        "certain",
        "type",
        "prostate",
        "cancer",
        "using",
        "novel",
        "clinical",
        "trial"
    ]
}